SCHEMBL10153374

SCHEMBL10153374

CC(C)c1ccc(N=CC=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.53
TYR P14679 3/20 0.48
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
GRIN2D O15399 2/20 0.37
GRIN3B O60391 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2A Q12879 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13590027 0.82 S100B (0.50) CYP2C9ALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL17770822 0.76 CYP2C9 (0.59) CYP2C9TYRALDH1A1MAPTNPC1
SCHEMBL7091916 0.76 ALDH1A1 (0.48) CYP2C9ALDH1A1MAPTNPC1RAB9A
SCHEMBL7626811 0.76 CYP2C9 (0.59) CYP2C9TYRALDH1A1MAPTNPC1
SCHEMBL85152 0.76 MAPT (0.47) CYP2C9ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL13322471 0.73 CYP3A4 (0.41) CYP1A2CYP3A4S100BMAPK1
SCHEMBL13805424 0.71 CYP2C9 (0.53) CYP2C9ALDH1A1MAPTCYP3A4HPGD
SCHEMBL13854131 0.71 CYP2C9 (0.53) CYP2C9TYRALDH1A1MAPTNPC1
SCHEMBL14459430 0.71 S100B (0.49) ALDH1A1MAPTNPC1RAB9AGAA
SCHEMBL18104433 0.71 CYP2C9 (0.49) CYP2C9TYRALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329907-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2012-12-11 US disclosed
US-8173638-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-08 US disclosed
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 US disclosed
US-20100009964-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009964-A1 Compounds Which Modulate The CB2 Receptor CNR2, CNR1, OPRL1 CYP2C9 1301/4885TYR 2164/4885ALDH1A1 1695/4885
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 CYP2C9 4824/4885TYR 3695/4885ALDH1A1 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.